Promimic AB
STO:PRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Promimic AB
Net Income (Common)
Promimic AB
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Promimic AB
STO:PRO
|
Net Income (Common)
-kr8.8m
|
CAGR 3-Years
18%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stendorren Fastigheter AB
STO:STEF B
|
Net Income (Common)
kr148m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
S
|
Swedish Logistic Property AB
STO:SLP B
|
Net Income (Common)
kr726m
|
CAGR 3-Years
20%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Cibus Nordic Real Estate AB (publ)
STO:CIBUS
|
Net Income (Common)
€89.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
FastPartner AB
STO:FPAR A
|
Net Income (Common)
kr331.7m
|
CAGR 3-Years
100%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
A
|
Asmodee Group AB
STO:ASMDEE B
|
Net Income (Common)
€4.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Promimic AB
Glance View
Promimic AB operates as a holding company that develops and markets implant surface modifications and synthetic bone based on a patented method for production of nano sized hydroxyapatite. The company is headquartered in Moelndal, Vastra Gotalands. The company went IPO on 2022-04-29. The firm manufactures, markets and sells biomaterials for improved osseointegration (bone healing) to the companies in the markets for orthopedic and dental implants. The firm operates primarily in the United States, Europe, and South America, with current product applications in the dental, spine, total joint, extremities, and sports medicine implant markets.
See Also
What is Promimic AB's Net Income (Common)?
Net Income (Common)
-8.8m
SEK
Based on the financial report for Dec 31, 2025, Promimic AB's Net Income (Common) amounts to -8.8m SEK.
What is Promimic AB's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
8%
Over the last year, the Net Income (Common) growth was 30%. The average annual Net Income (Common) growth rates for Promimic AB have been 18% over the past three years , 8% over the past five years .
